GRM Overseas Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 1, 2025, 5:18 pm

Quick Insight

GRM Overseas Ltd, a player in the Agricultural Products industry, currently trades at ₹373 with a MarketCap of ₹2,236 Cr. Despite a P/E ratio of 43.8, the company boasts a respectable ROE of 14.6% and ROCE of 12.0%. With an OPM of 11%, the company generated a Net Profit of ₹51 Cr. The strong promoter holding of 70.84% signals confidence, although institutional ownership is relatively low. The healthy reserves of ₹380 Cr provide a cushion against the ₹364 Cr in borrowings, while the P/BV ratio of 3.71x suggests the stock may be slightly overvalued. The Interest Coverage Ratio of 5.95x indicates the company can comfortably service its debt. Overall, investors should closely monitor GRM Overseas for potential entry points given its solid financial performance but should exercise caution due to the high valuation multiples.

Competitors of GRM Overseas Ltd

All Competitor Stocks of GRM Overseas Ltd

Quarterly Result

Last Updated: May 31, 2025, 5:49 am

Below is a detailed analysis of the quarterly data for GRM Overseas Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 243.00 Cr.. The value appears to be declining and may need further review. It has decreased from 245.00 Cr. (Dec 2024) to 243.00 Cr., marking a decrease of 2.00 Cr..
• For Expenses, as of Mar 2025, the value is 216.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 235.00 Cr. (Dec 2024) to 216.00 Cr., marking a decrease of 19.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Dec 2024) to 27.00 Cr., marking an increase of 17.00 Cr..
• For OPM %, as of Mar 2025, the value is 11.00%. The value appears strong and on an upward trend. It has increased from 4.00% (Dec 2024) to 11.00%, marking an increase of 7.00%.
• For Other Income, as of Mar 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Dec 2024) to 4.00 Cr., marking a decrease of 7.00 Cr..
• For Interest, as of Mar 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.00 Cr. (Dec 2024) to 8.00 Cr., marking an increase of 4.00 Cr..
• For Depreciation, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Dec 2024) to 23.00 Cr., marking an increase of 7.00 Cr..
• For Tax %, as of Mar 2025, the value is 30.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Dec 2024) to 30.00%, marking an increase of 4.00%.
• For Net Profit, as of Mar 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Dec 2024) to 16.00 Cr., marking an increase of 4.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 2.64. The value appears strong and on an upward trend. It has increased from 1.99 (Dec 2024) to 2.64, marking an increase of 0.65.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:07 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:10 pm

Below is a detailed analysis of the balance sheet data for GRM Overseas Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
• For Reserves, as of Mar 2025, the value is 380.00 Cr.. The value appears strong and on an upward trend. It has increased from 294.00 Cr. (Mar 2024) to 380.00 Cr., marking an increase of 86.00 Cr..
• For Borrowings, as of Mar 2025, the value is 364.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 393.00 Cr. (Mar 2024) to 364.00 Cr., marking a decrease of 29.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 109.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 38.00 Cr. (Mar 2024) to 109.00 Cr., marking an increase of 71.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 865.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 737.00 Cr. (Mar 2024) to 865.00 Cr., marking an increase of 128.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 39.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Mar 2024) to 39.00 Cr., marking an increase of 3.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 12.00 Cr., marking an increase of 10.00 Cr..
• For Other Assets, as of Mar 2025, the value is 814.00 Cr.. The value appears strong and on an upward trend. It has increased from 700.00 Cr. (Mar 2024) to 814.00 Cr., marking an increase of 114.00 Cr..
• For Total Assets, as of Mar 2025, the value is 865.00 Cr.. The value appears strong and on an upward trend. It has increased from 737.00 Cr. (Mar 2024) to 865.00 Cr., marking an increase of 128.00 Cr..

Notably, the Reserves (380.00 Cr.) exceed the Borrowings (364.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for GRM Overseas Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 10.21. This value is within the healthy range. It has increased from 9.96 (Mar 24) to 10.21, marking an increase of 0.25.
• For Diluted EPS (Rs.), as of Mar 25, the value is 8.87. This value is within the healthy range. It has decreased from 9.96 (Mar 24) to 8.87, marking a decrease of 1.09.
• For Cash EPS (Rs.), as of Mar 25, the value is 10.72. This value is within the healthy range. It has decreased from 10.73 (Mar 24) to 10.72, marking a decrease of 0.01.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 70.94. It has increased from 54.79 (Mar 24) to 70.94, marking an increase of 16.15.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 70.94. It has increased from 55.11 (Mar 24) to 70.94, marking an increase of 15.83.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 224.70. It has increased from 218.74 (Mar 24) to 224.70, marking an increase of 5.96.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 17.60. This value is within the healthy range. It has increased from 17.45 (Mar 24) to 17.60, marking an increase of 0.15.
• For PBIT / Share (Rs.), as of Mar 25, the value is 17.08. This value is within the healthy range. It has increased from 16.84 (Mar 24) to 17.08, marking an increase of 0.24.
• For PBT / Share (Rs.), as of Mar 25, the value is 14.12. This value is within the healthy range. It has increased from 13.41 (Mar 24) to 14.12, marking an increase of 0.71.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 10.21. This value is within the healthy range. It has increased from 10.12 (Mar 24) to 10.21, marking an increase of 0.09.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 10.21. This value is within the healthy range. It has increased from 9.96 (Mar 24) to 10.21, marking an increase of 0.25.
• For PBDIT Margin (%), as of Mar 25, the value is 7.83. This value is below the healthy minimum of 10. It has decreased from 7.97 (Mar 24) to 7.83, marking a decrease of 0.14.
• For PBIT Margin (%), as of Mar 25, the value is 7.60. This value is below the healthy minimum of 10. It has decreased from 7.69 (Mar 24) to 7.60, marking a decrease of 0.09.
• For PBT Margin (%), as of Mar 25, the value is 6.28. This value is below the healthy minimum of 10. It has increased from 6.13 (Mar 24) to 6.28, marking an increase of 0.15.
• For Net Profit Margin (%), as of Mar 25, the value is 4.54. This value is below the healthy minimum of 5. It has decreased from 4.62 (Mar 24) to 4.54, marking a decrease of 0.08.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.54. This value is below the healthy minimum of 8. It has decreased from 4.55 (Mar 24) to 4.54, marking a decrease of 0.01.
• For Return on Networth / Equity (%), as of Mar 25, the value is 14.38. This value is below the healthy minimum of 15. It has decreased from 18.18 (Mar 24) to 14.38, marking a decrease of 3.80.
• For Return on Capital Employeed (%), as of Mar 25, the value is 23.71. This value is within the healthy range. It has decreased from 30.10 (Mar 24) to 23.71, marking a decrease of 6.39.
• For Return On Assets (%), as of Mar 25, the value is 6.72. This value is within the healthy range. It has decreased from 7.76 (Mar 24) to 6.72, marking a decrease of 1.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.85. This value is within the healthy range. It has decreased from 1.20 (Mar 24) to 0.85, marking a decrease of 0.35.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.60. It has decreased from 1.69 (Mar 24) to 1.60, marking a decrease of 0.09.
• For Current Ratio (X), as of Mar 25, the value is 1.80. This value is within the healthy range. It has increased from 1.67 (Mar 24) to 1.80, marking an increase of 0.13.
• For Quick Ratio (X), as of Mar 25, the value is 1.14. This value is within the healthy range. It has decreased from 1.17 (Mar 24) to 1.14, marking a decrease of 0.03.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.90. This value is below the healthy minimum of 4. It has decreased from 3.60 (Mar 24) to 2.90, marking a decrease of 0.70.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.95. This value is within the healthy range. It has increased from 5.08 (Mar 24) to 5.95, marking an increase of 0.87.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.45. This value is within the healthy range. It has increased from 3.95 (Mar 24) to 4.45, marking an increase of 0.50.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,892.30. It has increased from 1,097.65 (Mar 24) to 1,892.30, marking an increase of 794.65.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has increased from 0.83 (Mar 24) to 1.40, marking an increase of 0.57.
• For EV / EBITDA (X), as of Mar 25, the value is 17.92. This value exceeds the healthy maximum of 15. It has increased from 10.48 (Mar 24) to 17.92, marking an increase of 7.44.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has increased from 0.54 (Mar 24) to 1.17, marking an increase of 0.63.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 3.71. This value exceeds the healthy maximum of 3. It has increased from 2.17 (Mar 24) to 3.71, marking an increase of 1.54.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has increased from 0.54 (Mar 24) to 1.17, marking an increase of 0.63.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 24) to 0.03, marking a decrease of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness